The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 03, 2023

Filed:

Jul. 01, 2021
Applicant:

Silverback Therapeutics, Inc., Seattle, WA (US);

Inventors:

Peter R. Baum, Seattle, WA (US);

Robert Dubose, Seattle, WA (US);

Valerie Odegard, Seattle, WA (US);

Philip Tan, Seattle, WA (US);

Peter A. Thompson, Seattle, WA (US);

Sean W. Smith, Seattle, WA (US);

Brenda Stevens, Seattle, WA (US);

Assignee:

SILVERBACK THERAPEUTICS, INC., Seattle, WA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 47/68 (2017.01); C07K 16/28 (2006.01); A61K 31/55 (2006.01); A61K 45/06 (2006.01); A61K 47/65 (2017.01); A61K 39/00 (2006.01); A61P 31/20 (2006.01);
U.S. Cl.
CPC ...
A61K 47/6803 (2017.08); A61K 31/55 (2013.01); A61K 45/06 (2013.01); A61K 47/65 (2017.08); A61K 47/6849 (2017.08); A61P 31/20 (2018.01); C07K 16/2851 (2013.01); A61K 2039/505 (2013.01); C07K 2317/24 (2013.01); C07K 2317/33 (2013.01);
Abstract

The disclosure provides conjugates of anti-ASGR1 antibodies or antigen binding fragments thereof to a myeloid cell agonist, compositions comprising the conjugates, and methods of treating liver viral infections with the conjugates. The disclosure also provides for anti-ASGR1 antibodies or antigen binding fragments thereof and methods for using the antibodies or antigen binding fragments thereof in treating liver viral infections.


Find Patent Forward Citations

Loading…